Centrum Medyczne Care Clinic Katowice

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Bipolar disorder1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Completed3 trials

Lead sponsor

• Janssen Pharmaceutica N.V., Belgium1 trial
• Janssen Research & Development, LLC1 trial
• Janssen-Cilag Ltd.1 trial

Closed trials

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of JNJ-55308942 in the Treatment of Bipolar Depression

  NCT05328297· Phase 2· Janssen Pharmaceutica N.V., Belgium· Source

• Completed

  A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

  NCT04829318· Phase 4· Janssen-Cilag Ltd.· Source